微信关注
China
Total item
Cart Subtotal
￥ 0.00 产品详情
Dipyridamole (Persantine)是一种磷酸二酯酶抑制剂，可阻止红细胞和血管内皮细胞摄取和代谢腺苷。
靶点信息
| PDE | ||||
| In vitro | DMSO | 99 mg/mL (196.18 mM) | |
| Water | Insoluble | ||
| Ethanol | 49 mg/mL (97.1 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 19.82 mL | 99.08 mL | 198.16 mL |
| 0.5 mM | 3.96 mL | 19.82 mL | 39.63 mL |
| 1 mM | 1.98 mL | 9.91 mL | 19.82 mL |
| 5 mM | 0.4 mL | 1.98 mL | 3.96 mL |
*The above data is based on the productmolecular weight 504.63. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A10319 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 504.63 |
| Formula | C24H40N8O4 |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 58-32-2 |
| Synonyms | Dipridacot, Dipyridamol, Persantin |
| SMILES | C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO |
产品标签
Product Questions
Product Questions
No Questions
Keywords:购买 Dipyridamole | Dipyridamole 供应商 | 订购 Dipyridamole | Dipyridamole 价格 | Dipyridamole 生产商 | 订单 Dipyridamole | Dipyridamole 代理商 | 购买 58-32-2| 58-32-2 供应商 | 订购 58-32-2 | 58-32-2 价格 | 58-32-2 生产商 | 订单 58-32-2 | 58-32-2 代理商|buy Dipyridamole | Dipyridamole Supplier | purchase Dipyridamole | Dipyridamole cost | Dipyridamole manufacturer | order Dipyridamole | Dipyridamole distributor | buy 58-32-2| 58-32-2 Supplier | purchase 58-32-2 | 58-32-2 cost | 58-32-2 manufacturer | order 58-32-2 | 58-32-2 distributor
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
ADOOQ 产品质量保证
We promise all products to perform as described.